Jessica Shull's guest appearances

Jessica Shull

Faces of Digital Health

Digital Orthopaedics Conference (DOCSF)

DTx Podcast with Eugene Borukhovich

Eugene Borukhovich

Daniel Kraft

Dean Ornish

Chris Bowen

Chris Johnson

Amy Brown

Richard Lee

Esther Wojcicki

Samson Williams

Tim Peck

Esther Dyson

Richard Jacobs

Bill Rogers

Robert Miller

Casey Ross

OwlTail

In this episode, we have a combined Q&amp;A about virtual humans and digital therapeutics. We are joined on the virtual stage by Erica Lloyd from Soul Machines and Jessica Shull from Digital Therapeutics Alliance. Erica shares what she does with Soul Machines, a company dedicated to humanizing AI. With her colleague Shantenu Agarwal, they talk about chatbots and their application in healthcare. The future is in the combination of technologies to create a more empathetic digital person. A digital brain is a system created to understand and react accordingly and process information as an output. Soul Machines, led by Shantenu and Erica, are transforming the industry with their AI products. Jessica guides us through the digital therapeutics ecosystem. The goal of the Alliance is to engage with every character and stakeholder involved in therapeutics. These are not only the companies; these include patients, clinicians, research institutions, and universities. She also defines what a digital therapeutic is and what they require to be in the market. Digital therapeutics don’t necessarily work on their own. They work better in conjunction with other products like telehealth and sensors. Join this amazing conversation about digital therapeutics, chatbots, and virtual humans. It may be intimidating, but it is the future of technology!

In this episode, we have a combined Q&amp;A about virtual humans and digital therapeutics. We are joined on the virtual stage by Erica Lloyd from Soul Machines and Jessica Shull from Digital Therapeutics Alliance. Erica shares what she does with Soul Machines, a company dedicated to humanizing AI. With her colleague Shantenu Agarwal, they talk about chatbots and their application in healthcare. The future is in the combination of technologies to create a more empathetic digital person. A digital brain is a system created to understand and react accordingly and process information as an output. Soul Machines, led by Shantenu and Erica, are transforming the industry with their AI products. Jessica guides us through the digital therapeutics ecosystem. The goal of the Alliance is to engage with every character and stakeholder involved in therapeutics. These are not only the companies; these include patients, clinicians, research institutions, and universities. She also defines what a digital therapeutic is and what they require to be in the market. Digital therapeutics don’t necessarily work on their own. They work better in conjunction with other products like telehealth and sensors.  Join this amazing conversation about digital therapeutics, chatbots, and virtual humans. It may be intimidating, but it is the future of technology!

S8E08 -  The Patient Experience: Chatbots + Digital Therapeutics with Erica Lloyd, Shantenu Agarwal & Jessica Shull 

LEAD

In the previous episode in this two-part deep dive inside the Digital Therapeutics Alliance, I spoke to Megan Coder, the Executive Director for the DTA. In this episode, I'm excited to chat with Jessica Shull, European lead for the DTA. I met Jessica and Sitges, Spain near Barcelona at a HIMSS EU Health 2.0 event. Jessica struck me as sharp, composed and super knowledgeable, and of course, a great addition to the DTA. With Jessica's leadership, the DTA expanded its coverage across Europe, LATAM and Australia.Click here to read the transcriptLinks and Resources: Connect with Jessica Shull: Twitter | LinkedIn  Visit the Digital Therapeutics Alliance  Connect with Eugene Borukhovich: Twitter | LinkedIn  Connect with YourCoach.health: Website | Twitter  Subscribe to Exits &amp; Outcomes  Brian Dolan: Twitter | LinkedIn  HealthXL: Website | Twitter | Join an Event  Follow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | InstagramDigital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche 

In the previous episode in this two-part deep dive inside the Digital Therapeutics Alliance, I spoke to Megan Coder, the Executive Director for the DTA. In this episode, I'm excited to chat with Jessica Shull, European lead for the DTA. I met Jessica and Sitges, Spain near Barcelona at a HIMSS EU Health 2.0 event. Jessica struck me as sharp, composed and super knowledgeable, and of course, a great addition to the DTA. With Jessica's leadership, the DTA expanded its coverage across Europe, LATAM and Australia.<a href="https://digitalhealthtoday.com/transcripts/ep04-jessica-shull-transcript/" rel="nofollow" target="_blank">Click here to read the transcript</a>Links and Resources:<ul> <li>Connect with Jessica Shull: <a href="https://twitter.com/jgshull" rel="nofollow" target="_blank">Twitter </a>| <a href="https://www.linkedin.com/in/jessica-shull-b8655b7/?originalSubdomain=es" rel="nofollow" target="_blank">LinkedIn</a> </li> <li>Visit the <a href="https://dtxalliance.org/" rel="nofollow" target="_blank">Digital Therapeutics Alliance</a> </li> <li>Connect with Eugene Borukhovich: <a href="https://twitter.com/healtheugene" rel="nofollow" target="_blank">Twitter</a> | <a href="https://www.linkedin.com/in/healtheugene/" rel="nofollow" target="_blank">LinkedIn</a> </li> <li>Connect with YourCoach.health: <a href="https://yourcoach.health/" rel="nofollow" target="_blank">Website</a> | <a href="https://twitter.com/yourcoachhealth" rel="nofollow" target="_blank">Twitter</a> </li> <li>Subscribe to <a href="https://exitsandoutcomes.com/" rel="nofollow" target="_blank">Exits &amp; Outcomes</a> </li> <li>Brian Dolan: <a href="https://twitter.com/bddol" rel="nofollow" target="_blank">Twitter</a> | <a href="https://www.linkedin.com/in/bddolan/" rel="nofollow" target="_blank">LinkedIn</a> </li> <li>HealthXL: <a href="https://www.healthxl.com/" rel="nofollow" target="_blank">Website</a> | <a href="https://twitter.com/health_xl" rel="nofollow" target="_blank">Twitter</a> | <a href="https://cms.megaphone.fm/organizations/6f5f92a2-7984-11e8-bcfc-b715c2319eab/podcasts/eb6f8c06-8435-11e8-994b-2f65b72d51ca/episodes/8c49f7f0-7e3b-11ea-919f-c32e1e4c8b6d/healthxl.com/events" rel="nofollow" target="_blank">Join an Event</a> </li> </ul> Follow Digital Health Today:<a href="https://digitalhealthtoday.com/podcasts" rel="nofollow" target="_blank">Browse Episodes</a> | <a href="https://twitter.com/dhealthtoday" rel="nofollow" target="_blank">Twitter</a> | <a href="https://www.linkedin.com/company/digital-health-today/" rel="nofollow" target="_blank">LinkedIn</a> | <a href="https://facebook.com/digitalhealthtoday" rel="nofollow" target="_blank">Facebook</a> | <a href="https://www.instagram.com/digitalhealthtoday/" rel="nofollow" target="_blank">Instagram</a>Follow Health Podcast Network:<a href="https://healthpodcastnetwork.com/" rel="nofollow" target="_blank">Browse Shows</a> | <a href="https://www.linkedin.com/showcase/health-podcast-network/" rel="nofollow" target="_blank">LinkedIn</a> | <a href="https://twitter.com/healthpodnet" rel="nofollow" target="_blank">Twitter</a> | <a href="https://www.facebook.com/healthpodnet" rel="nofollow" target="_blank">Facebook</a> | <a href="https://www.instagram.com/healthpodnet/" rel="nofollow" target="_blank">Instagram</a>Digital Health Today is made possible by the<a href="https://digitalhealthtoday.com/partners-sponsors/" rel="nofollow" target="_blank"> support of our sponsors</a>. Thank you to:<ul> <li><a href="https://digitalhealthtoday.com/partners-sponsors/" rel="nofollow" target="_blank">Bayer G4A</a></li> <li><a href="https://digitalhealthtoday.com/partners-sponsors/" rel="nofollow" target="_blank">Cedars-Sinai Accelerator</a></li> <li><a href="https://digitalhealthtoday.com/partners-sponsors/" rel="nofollow" target="_blank">Takeda</a></li> <li><a href="https://digitalhealthtoday.com/partners-sponsors/" rel="nofollow" target="_blank">Roche</a></li> </ul>

Ep04: Digital Therapeutics Alliance, Deep Dive Part 2 with Jessica Shull, European Lead

Digital therapeutics (DTx) are clinically validated digital solutions with proven positive effects on disease management and outcomes. in this episode, Jessica Shull, European Lead for the Digital Therapeutics Alliance, shaping advocacy and organizational engagement for the DTx industry in European countries, explains what DTx are, why are they relevant clinical interventions, how do clinical trials for medications differ from clinical trials for digital therapeutics. Jessica also explains what digital therapeutics are and how they should be differentiated from digital diagnostics and more.As written by the Digital Health Alliance, DTx have immense potential in the coronavirus pandemic, because patient access to and utilization of digital therapeutics could improve health outcomes, consequently reducing chronic disease-related hospitalizations, mitigating additional pressures on healthcare providers during the COVID-19 outbreak. Their use could reduce vulnerable populations’ potential coronavirus exposure.Announcement: Jessica Shull will be at the Eyeforpharma virtual conference taking place between March 30th and April 3rd! Go to: https://www.eyeforpharma.com/barcelona/ Resources: Recap of the showApple COVID-19 screening toolWHO Whatsapp service for COVID-19 informationDTx and COVID-19

Digital therapeutics (DTx) are clinically validated digital solutions with proven positive effects on disease management and outcomes. in this episode, Jessica Shull, European Lead for the Digital Therapeutics Alliance, shaping advocacy and organizational engagement for the DTx industry in European countries, explains what DTx are, why are they relevant clinical interventions, how do clinical trials for medications differ from clinical trials for digital therapeutics. Jessica also explains what digital therapeutics are and how they should be differentiated from digital diagnostics and more. As written by the Digital Health Alliance, DTx have immense potential in the coronavirus pandemic, because patient access to and utilization of digital therapeutics could improve health outcomes, consequently reducing chronic disease-related hospitalizations, mitigating additional pressures on healthcare providers during the COVID-19 outbreak. Their use could reduce vulnerable populations’ potential coronavirus exposure. Announcement: Jessica Shull will be at the Eyeforpharma virtual conference taking place between March 30th and April 3rd! Go to: <a href="https://www.eyeforpharma.com/barcelona/" rel="nofollow" target="_blank">https://www.eyeforpharma.com/barcelona/</a>   Resources:  Recap of the show Apple COVID-19 screening toolWHO Whatsapp service for COVID-19 informationDTx and COVID-19

F072 DTx series 1/5: How do DTx differ from medications or digital health apps? (Jessica Shull)